TL;DR
This study investigates the diagnostic potential of circulating microRNAs (miRNAs) for hypertension. By analyzing serum samples from hypertensive and healthy individuals, the researchers identified a combination of four specific miRNAs (miR-199a-3p, miR-208a-3p, miR-122-5p, and miR-223-3p) that demonstrates a strong diagnostic performance, offering a promising avenue for early hypertension detection.
What Problem Does This Paper Address?
Hypertension is a major global health concern, significantly increasing the risk of cardiovascular diseases, chronic kidney failure, and stroke. Early and accurate detection is crucial for effective management and prevention of these complications. While microRNAs (miRNAs) have emerged as potential biomarkers for various diseases, including hypertension, previous studies have often focused on individual miRNAs or used varying normalization methods, leading to inconsistent results and a lack of comprehensive understanding of their diagnostic utility in a single cohort. This paper aims to address this by systematically evaluating the performance of previously reported hypertension-associated miRNAs in a unified cohort and exploring the underlying biological pathways they might influence.
Methods
The study employed a multi-faceted approach:
- Serum Sample Collection and miRNA Profiling: Serum samples were collected from 164 participants (53 hypertensive, 111 healthy controls). RNA was isolated from these samples, and the expression levels of 25 candidate miRNAs were quantified using quantitative reverse transcription polymerase chain reaction (RT-qPCR).
- Reference Gene Selection: To ensure accurate miRNA quantification, the stability of seven potential reference genes (miR-16, U6 snRNA, 5S ribosomal RNA, miR-19b, miR-15b, miR-24, and let-7i) was evaluated using BestKeeper, NormFinder, and comparative ΔCq analysis. miR-16 was identified as the most stable reference gene.
- Diagnostic Performance Evaluation: Receiver Operating Characteristic (ROC) curves were generated to assess the diagnostic accuracy of individual miRNAs and their combinations in distinguishing between hypertensive and normal individuals. Area Under the Curve (AUC) values were calculated to quantify performance.
- Bioinformatics Analysis: The miRWALK2.0 webserver was utilized to predict target genes for the identified candidate miRNAs. Subsequently, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was performed using DAVID to identify biological pathways that are significantly enriched with these target genes.
Datasets
The study utilized serum samples from a cohort of 164 participants recruited from the China National Heart Failure Registry (CN-HF). This registry is a national, multicentered, prospective, and observational study. The cohort comprised 53 patients diagnosed with hypertension and 111 individuals from the normal population.
Key Insights and Ideas
- A Promising miRNA Combination for Hypertension Diagnosis: The study highlights that while individual miRNAs show some diagnostic capability, a specific combination of four miRNAs (miR-199a-3p, miR-208a-3p, miR-122-5p, and miR-223-3p) offers a significantly improved diagnostic performance for hypertension. This suggests a synergistic effect of these miRNAs in disease detection.
- miRNAs as Indicators of Myocardial Injury and Cardiac Function: Beyond their role in hypertension diagnosis, several of the identified miRNAs (e.g., miR-1-3p, miR-20b-5p, miR-548c-3p, miR-499a-5p) showed significant correlations with indicators of myocardial injury (like cTNT) and cardiac function (like BNP and LVEF). This hints at their potential as broader cardiovascular risk biomarkers.
- Complex miRNA-Gene-Pathway Interactions: The bioinformatics analysis revealed that these candidate miRNAs collectively target a large number of genes, impacting numerous KEGG pathways. This underscores the intricate regulatory roles of miRNAs in the complex pathophysiology of hypertension.
- FoxO Signaling Pathway as a Key Player: The FoxO signaling pathway emerged as a significantly enriched pathway targeted by multiple candidate miRNAs (miR-199a-3p, miR-208a-3p, and miR-122-5p). This pathway is known to be involved in critical cellular processes relevant to vascular health and hypertension.
Key Results
- Individual miRNA Performance: Several miRNAs demonstrated moderate diagnostic performance, with miR-122-5p (AUC: 0.750), miR-199a-3p (AUC: 0.744), and miR-208a-3p (AUC: 0.743) showing the best individual predictive abilities.
- Combined miRNA Performance: The combination of five miRNAs (miR-199a-3p, miR-208a-3p, miR-423p, miR-122-5p, and miR-223-5p) achieved an AUC of 0.798. The best performance was observed with the combination of four miRNAs: miR-199a-3p, miR-208a-3p, miR-122-5p, and miR-223-3p, yielding an AUC of 0.80.
- Pathway Enrichment: The analysis identified 94 KEGG pathways enriched with genes targeted by the candidate miRNAs. The FoxO signaling pathway was notably enriched by three of the four top miRNAs.
- Correlation with Biochemical Markers: Significant correlations were found between specific miRNAs and biochemical indicators such as BNP, cTNT, and LVEF, suggesting their involvement in cardiac function and injury.
Limitations and Future Work
The authors acknowledge several limitations:
- Scope of miRNA Analysis: Due to the vast number of miRNAs, the study could only select a subset of previously reported miRNAs, rather than performing a comprehensive analysis of all known miRNAs.
- Subgroup Analysis: The study did not perform subgroup analysis based on different types of hypertension, which could lead to variations in miRNA expression.
Future work could involve:
- Experimental Validation: The study's findings, particularly the pathway enrichment analysis, would benefit from experimental validation to confirm the direct interactions and functional consequences of these miRNAs in hypertension.
- Clinical Validation: Larger, prospective clinical trials are needed to validate the diagnostic utility of the identified miRNA combination in diverse patient populations.
- Mechanistic Studies: Further research is required to elucidate the precise mechanisms by which these miRNAs and their target pathways contribute to the pathogenesis of hypertension.
Summary updated